Karen is a Research Fellow in the Faculty of Business and Economics at Monash University. She has over ten years of experience evaluating the clinical- and cost-effectiveness of medical technologies for funding on national insurance schemes.  This includes the development of modelled economic evaluations as well as reviews of funded technologies to ensure continued value for money.  Her work has directly informed recommendations by the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC) in Australia, and the Agency for Care Effectiveness (ACE) in Singapore. 

Other research interests include economic modelling, funding decisions by health technology assessment committees, including using drug reimbursement data in Australia.